Inhibition of elongation factor-2 kinase augments the antitumor activity of Temozolomide against glioma.
Glioblastoma multiforme (GBM), the most common form of brain cancer with an average survival of less than 12 months, is a highly aggressive and fatal disease characterized by survival of glioma cells following initial treatment, invasion through the brain parenchyma and destruction of normal brain t...
| Main Authors: | , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2013-01-01
|
| Series: | PLoS ONE |
| Online Access: | http://europepmc.org/articles/PMC3841121?pdf=render |
| _version_ | 1828864754450432000 |
|---|---|
| author | Xiao-Yuan Liu Li Zhang Jianping Wu Lei Zhou Yi-Jie Ren Wei-Qiong Yang Zi-Jun Ming Bo Chen Jianrong Wang Yi Zhang Jin-Ming Yang |
| author_facet | Xiao-Yuan Liu Li Zhang Jianping Wu Lei Zhou Yi-Jie Ren Wei-Qiong Yang Zi-Jun Ming Bo Chen Jianrong Wang Yi Zhang Jin-Ming Yang |
| author_sort | Xiao-Yuan Liu |
| collection | DOAJ |
| description | Glioblastoma multiforme (GBM), the most common form of brain cancer with an average survival of less than 12 months, is a highly aggressive and fatal disease characterized by survival of glioma cells following initial treatment, invasion through the brain parenchyma and destruction of normal brain tissues, and ultimately resistance to current treatments. Temozolomide (TMZ) is commonly used chemotherapy for treatment of primary and recurrent high-grade gliomas. Nevertheless, the therapeutic outcome of TMZ is often unsatisfactory. In this study, we sought to determine whether eEF-2 kinase affected the sensitivity of glioma cells to treatment with TMZ.Using RNA interference approach, a small molecule inhibitor of eEF-2 kinase, and in vitro and in vivo glioma models, we observed that inhibition of eEF-2 kinase could enhance sensitivity of glioma cells to TMZ, and that this sensitizing effect was associated with blockade of autophagy and augmentation of apoptosis caused by TMZ.These findings demonstrated that targeting eEF-2 kinase can enhance the anti-glioma activity of TMZ, and inhibitors of this kinase may be exploited as chemo-sensitizers for TMZ in treatment of malignant glioma. |
| first_indexed | 2024-12-13T04:12:51Z |
| format | Article |
| id | doaj.art-939de2f47b0a4aadbc44f4ad522e2565 |
| institution | Directory Open Access Journal |
| issn | 1932-6203 |
| language | English |
| last_indexed | 2024-12-13T04:12:51Z |
| publishDate | 2013-01-01 |
| publisher | Public Library of Science (PLoS) |
| record_format | Article |
| series | PLoS ONE |
| spelling | doaj.art-939de2f47b0a4aadbc44f4ad522e25652022-12-21T23:59:57ZengPublic Library of Science (PLoS)PLoS ONE1932-62032013-01-01811e8134510.1371/journal.pone.0081345Inhibition of elongation factor-2 kinase augments the antitumor activity of Temozolomide against glioma.Xiao-Yuan LiuLi ZhangJianping WuLei ZhouYi-Jie RenWei-Qiong YangZi-Jun MingBo ChenJianrong WangYi ZhangJin-Ming YangGlioblastoma multiforme (GBM), the most common form of brain cancer with an average survival of less than 12 months, is a highly aggressive and fatal disease characterized by survival of glioma cells following initial treatment, invasion through the brain parenchyma and destruction of normal brain tissues, and ultimately resistance to current treatments. Temozolomide (TMZ) is commonly used chemotherapy for treatment of primary and recurrent high-grade gliomas. Nevertheless, the therapeutic outcome of TMZ is often unsatisfactory. In this study, we sought to determine whether eEF-2 kinase affected the sensitivity of glioma cells to treatment with TMZ.Using RNA interference approach, a small molecule inhibitor of eEF-2 kinase, and in vitro and in vivo glioma models, we observed that inhibition of eEF-2 kinase could enhance sensitivity of glioma cells to TMZ, and that this sensitizing effect was associated with blockade of autophagy and augmentation of apoptosis caused by TMZ.These findings demonstrated that targeting eEF-2 kinase can enhance the anti-glioma activity of TMZ, and inhibitors of this kinase may be exploited as chemo-sensitizers for TMZ in treatment of malignant glioma.http://europepmc.org/articles/PMC3841121?pdf=render |
| spellingShingle | Xiao-Yuan Liu Li Zhang Jianping Wu Lei Zhou Yi-Jie Ren Wei-Qiong Yang Zi-Jun Ming Bo Chen Jianrong Wang Yi Zhang Jin-Ming Yang Inhibition of elongation factor-2 kinase augments the antitumor activity of Temozolomide against glioma. PLoS ONE |
| title | Inhibition of elongation factor-2 kinase augments the antitumor activity of Temozolomide against glioma. |
| title_full | Inhibition of elongation factor-2 kinase augments the antitumor activity of Temozolomide against glioma. |
| title_fullStr | Inhibition of elongation factor-2 kinase augments the antitumor activity of Temozolomide against glioma. |
| title_full_unstemmed | Inhibition of elongation factor-2 kinase augments the antitumor activity of Temozolomide against glioma. |
| title_short | Inhibition of elongation factor-2 kinase augments the antitumor activity of Temozolomide against glioma. |
| title_sort | inhibition of elongation factor 2 kinase augments the antitumor activity of temozolomide against glioma |
| url | http://europepmc.org/articles/PMC3841121?pdf=render |
| work_keys_str_mv | AT xiaoyuanliu inhibitionofelongationfactor2kinaseaugmentstheantitumoractivityoftemozolomideagainstglioma AT lizhang inhibitionofelongationfactor2kinaseaugmentstheantitumoractivityoftemozolomideagainstglioma AT jianpingwu inhibitionofelongationfactor2kinaseaugmentstheantitumoractivityoftemozolomideagainstglioma AT leizhou inhibitionofelongationfactor2kinaseaugmentstheantitumoractivityoftemozolomideagainstglioma AT yijieren inhibitionofelongationfactor2kinaseaugmentstheantitumoractivityoftemozolomideagainstglioma AT weiqiongyang inhibitionofelongationfactor2kinaseaugmentstheantitumoractivityoftemozolomideagainstglioma AT zijunming inhibitionofelongationfactor2kinaseaugmentstheantitumoractivityoftemozolomideagainstglioma AT bochen inhibitionofelongationfactor2kinaseaugmentstheantitumoractivityoftemozolomideagainstglioma AT jianrongwang inhibitionofelongationfactor2kinaseaugmentstheantitumoractivityoftemozolomideagainstglioma AT yizhang inhibitionofelongationfactor2kinaseaugmentstheantitumoractivityoftemozolomideagainstglioma AT jinmingyang inhibitionofelongationfactor2kinaseaugmentstheantitumoractivityoftemozolomideagainstglioma |